Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report
Psychiatry and Clinical Neurosciences Reports · 2026-06 · 5 (2)
DOI: 10.1002/pcn5.70330 ↗Kurz gefasst
Fallbericht in der Zeitschrift Psychiatry and Clinical Neurosciences Reports, online erschienen am 07.04.2026. Verfasst von Toru Horinouchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Neurology Hokkaido University Hospital Sapporo Hokkaido Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Background
Treatment‐resistant schizophrenia (TRS) poses a substantial clinical challenge for which clozapine (CLOZ) is the only effective treatment. However, clinicians may hesitate to prescribe CLOZ for TRS patients with epilepsy due to its presence because CLOZ is contraindicated in patients with uncontrolled epilepsy in some countries including Japan. Case Presentation A 36‐year‐old male with TRS and focal epilepsy underwent CLOZ therapy. CLOZ was initiated at 6.25 mg and gradually titrated to 250 mg over 3 months, achieving a plasma concentration of 449 ng/mL. Psychotic symptoms improved without worsening of seizure frequency or severity. Mild side effects such as drowsiness and drooling were manageable. Long‐term video electroencephalography monitoring detected spike‐and‐wave activity centered in the frontal region, but did not detect any overt epileptic seizures.
Conclusion
We report a case of TRS with comorbid epilepsy in which CLOZ therapy was both effective and safe.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Neurology Hokkaido University Hospital Sapporo Hokkaido Japan.
- Epilepsy Center Hokkaido University Hospital Sapporo Hokkaido Japan.
- Department of Psychiatry Tokyo Metropolitan Matsuzawa Hospital Setagaya-ku Tokyo Japan.
ORCID-Profile: Toru Horinouchi
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Horinouchi, T., Mito, M., Ishikawa, T., Nakamura, Y., Ishikawa, S., & Hashimoto, N. (2026). Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report. Psychiatry and Clinical Neurosciences Reports, 5(2). https://doi.org/10.1002/pcn5.70330
Vancouver
Horinouchi T, Mito M, Ishikawa T, Nakamura Y, Ishikawa S, Hashimoto N. Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report. Psychiatry and Clinical Neurosciences Reports. 2026;5(2). doi:10.1002/pcn5.70330
BibTeX
@article{Horinouchi2026,
author = {Horinouchi, Toru and Mito, Mayusa and Ishikawa, Toshiyuki and Nakamura, Yuichi and Ishikawa, Shuhei and Hashimoto, Naoki},
title = {Clozapine for treatment‐resistant schizophrenia with epilepsy: A case report},
journal = {Psychiatry and Clinical Neurosciences Reports},
year = {2026},
volume = {5},
number = {2},
doi = {10.1002/pcn5.70330}
}
EUVIMED